Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design David KhayatOlivier RixeChristian Puozzo Original Article 25 May 2004 Pages: 193 - 205
Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors Katherine WarrenAnne GervaisFrank M. Balis Original Article 19 May 2004 Pages: 206 - 212
Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique M. ÖmanJ. TölliL. O. Hafström Original Article 11 May 2004 Pages: 213 - 218
Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes Srikanth C. NallaniBryan GoodwinPankaj B. Desai Original Article 03 June 2004 Pages: 219 - 229
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients Nagio TakigawaYoshihiko SegawaMitsune Tanimoto Original Article 04 May 2004 Pages: 230 - 236
Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children Marshall P. GorenSidnei EpelmanDorothy A. Bush Original Article 04 June 2004 Pages: 237 - 240
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies Warren A. ChowTimothy W. SynoldJames H. Doroshow Original Article 02 June 2004 Pages: 241 - 248
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer James W. DarnowskiFrederick A. GoulettePaul Calabresi Original Article 02 June 2004 Pages: 249 - 258
Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study George P. StathopoulosSotiris K. RigatosDimosthenis V. Skarlos Original Article 04 May 2004 Pages: 259 - 264
Dexamethasone as a probe for docetaxel clearance Florent PuissetEtienne ChatelutHenri Roché Original Article 05 May 2004 Pages: 265 - 272
Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study Jason A. SegretiJames S. PolakowskiGlenn A. Reinhart Original Article 02 June 2004 Pages: 273 - 281
